Board Meeting on June 24, 2016
Venus Remedies Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on June 24, 2016, inter alia, to consider the status of preferential issue of shares which was passed at last AGM, which is still pending for implementation.Further, in terms of SEBI (Prohibition of Insider Trading) Regulations, the Trading Window, for dealing in securities of the Company shall be closed from June 18, 2016 to June 26,... Standalone & Consolidated Financial Results, Form B, Auditors Report for March 31, 2016
Venus Remedies Ltd has informed BSE about : 1. Standalone Financial Results for the period ended March 31, 20162. Consolidated Financial Results for the period ended March 31, 20163. Standalone Form B for the period ended March 31, 20164. Standalone Auditors Report for the period ended March 31, 20165. Consolidated Auditors Report for the period ended March 31, 2016 Board Meeting Intimation for Results & Closure of Trading Window
Venus Remedies Ltd has informed BSE regarding "Board Meeting Intimation for Results & Closure of Trading Window". Venus launches its second OTC product "SWATCH GAURD" a herbal Hand Sanitizer
Venus Remedies Ltd has informed BSE regarding "Venus launches its second OTC product "SWATCH GAURD" a herbal Hand Sanitizer". Shareholding for the Period Ended March 31, 2016
Venus Remedies Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2016. For more details, kindly Click here Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended March 31, 2016
Venus Remedies Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended March 31, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
Venus Remedies Ltd has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
Venus Remedies Ltd has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
Venus Remedies Ltd has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE